Organization
Ionis Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Ionis Pharmaceuticals, Inc.
... America to Dominate the Market Notable Developments in the Market AstraZeneca licensed IONIS-AZ6-2.5-LRx, NASH drug from Ionis Pharmaceuticals, Inc. for USD 30 million.NorthSea Therapeutics B.V. ...
... Company (NYSE:SWN), DAQO New Energy Corp. (NYSE:DQ), ANGI Homeservices, Inc. (NASDAQ:ANGI), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), and Cronos Group Inc. (NASDAQ:CRON), including updated fundamental summaries, consolidated ...
... recent business and pipeline successes. 'With the approval of TEGSEDI in Europe, Ionis is entering a new chapter as a multi-product, sustainably profitable company. We ...
... the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to IONIS-HTTRx (also known as RG6042) for the treatment of people with Huntington's disease ...
... (PRIority MEdicines) designation for the company's investigational medicine RG6042 (formerly known as IONIS-HTTRx) for the treatment of people with Huntington's disease (HD). RG6042 has demonstrated ...
... Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the second quarter of 2018 ...
... (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious ...
... (PRIority MEdicines) designation for the company's investigational medicine RG6042 (formerly known as IONIS-HTTRx) for the treatment of people with Huntington's disease (HD). RG6042 has demonstrated ...
... Ionis Pharmaceuticals' IONIS-HTTRx is designed to address the cause of Huntington's disease by ...
Subscribe now for full coverage on Ionis Pharmaceuticals, Inc.
Start My Free Trial